If you have any questions or comments, please don't hesitate to contact us at [email protected]
If you know somebody who is affected by diabetes and who might benefit from the information diaTribe provides, tell them about us through Facebook, Twitter, or email.
Novo Nordisk’s PIONEER PLUS trial has delivered promising A1C and weight loss results for patients with type 2 diabetes taking the oral semaglutide Rybelsus at significantly higher doses. Continue Reading
Need help? Search free and reduced cost services like medical care, food, housing, and more in your area.
